trimethoprim tablets
aa pharma inc - trimethoprim - tablet - 200mg - trimethoprim 200mg - urinary anti-infectives
trimethoprim tablet
golden state medical supply, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of
trimethoprim 100mg tablets
ennogen pharma ltd - trimethoprim - oral tablet - 100mg
trimethoprim 200mg tablets
ennogen pharma ltd - trimethoprim - oral tablet - 200mg
trimethoprim tablet
novitium pharma llc - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets and other antibacterial drugs, trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the results of
trimethoprim tablet
golden state medical supply, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets and other antibacterial drugs, trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacter
tribactral s antibacterial solution for injection
intervet australia pty limited - trimethoprim; sulfadoxine - parenteral liquid/solution/suspension - trimethoprim pyrimidine active 40.0 mg/ml; sulfadoxine sulfanyl active 200.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - organisms sensitive to sulfadoxine | organisms sensitive to trimethoprim
tribrissen 20 tablets
intervet australia pty limited - trimethoprim; sulfadiazine - oral tablet - trimethoprim pyrimidine active 20.0 mg/tb; sulfadiazine sulfanyl active 100.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial infection | organisms sensitive to combination of | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria
tribrissen 80 tablets
intervet australia pty limited - trimethoprim; sulfadiazine - oral tablet - trimethoprim pyrimidine active 80.0 mg/tb; sulfadiazine sulfanyl active 400.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - bacterial infection | organisms sensitive to combination of | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria
primsol- trimethoprim hydrochloride solution
fsc laboratories, inc - trimethoprim hydrochloride (unii: 9xe000ou9b) (trimethoprim - unii:an164j8y0x) - trimethoprim 50 mg in 5 ml - primsol solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. for the treatment of acute otitis media due to susceptible strains of streptococcus pneumoniae and haemophilus influenzae. note: moraxella catarrhalis isolates were found consistently resistant to trimethoprim in vitro. therefore, when infection with moraxella catarrhalis is suspected, the use of alternative antimicrobial agents should be considered. primsol is not indicated for prophylactic or prolonged administration in otitis media at any age. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli, proteus mirabilis, klebsiella pneumoniae, enterobacter species and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim